CARMUSTINE DR REDDY'S carmustine 100 mg powder for injection vial with diluent vial

국가: 오스트레일리아

언어: 영어

출처: Department of Health (Therapeutic Goods Administration)

지금 구매하세요

Download 공공 평가 보고서 (PAR)
12-10-2020

유효 성분:

carmustine, Quantity: 100 mg

제공처:

Dr Reddys Laboratories Australia Pty Ltd

약제 형태:

Injection, diluent for

구성:

Excipient Ingredients: ethanol absolute

관리 경로:

Intravenous Infusion

패키지 단위:

1 powder for injection vial and 1 diluent vial

처방전 유형:

(S4) Prescription Only Medicine

치료 징후:

CARMUSTINE DR.REDDY'S is indicated as palliative therapy as a single agent or in established combination therapy with other approved chemotherapeutic agents in the following: 1. Malignant Glioma 2. Multiple Myeloma - in combination with prednisone. 3. Hodgkin?s Disease - as secondary therapy in combination with other approved drugs in patients who relapse while being treated with primary therapy, or who fail to respond to primary therapy. 4. Non-Hodgkin?s lymphomas - as secondary therapy in combination with other approved drugs for patients who relapse while being treated with primary therapy or who fail to respond to primary therapy.

제품 요약:

Visual Identification: Clear, colourless, mobile, volatile liquid; Container Type: Vial; Container Material: Glass Type I Coloured; Container Life Time: 24 Months; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

승인 상태:

Registered

승인 날짜:

2020-08-12